• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2000 Fiscal Year Final Research Report Summary

Mechanisms involved in GPI-anchored-protein signaling dimer formation

Research Project

Project/Area Number 10672190
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Laboratory medicine
Research InstitutionOsaka Medical College

Principal Investigator

HATANAKA Michiyo  Kobe Tokiwa College Associate Professor, 衛生技術科, 助教授 (50218484)

Project Period (FY) 1998 – 2000
KeywordsGPI-anchored protein / signal transduction / CD59 / dimer formation / T cell activation / caveolin / ATL
Research Abstract

Various cell surface proteins are anchored to cell membranes via a glycosyl-phosphatidylinositol (GPI) anchor. Although these proteins function as signaling molecules, mechanisms involved in the signaling are largely unknown. In this study we focused on a GPI-anchored complement regulatory protein, CD59, as a model for elucidating the mechanisms involved in the GPI-anchored protein mediating signaling.
We identified a CD59-associating protein by cross-linking surface proteins by chemical cross-linker and revealed that the protein is CD59 molecule itself. We also developed the method for direct measurement of CD59 signaling by means of a C9 peptide as a ligand. By ligation with the C9 peptide, specific increase in intracellular Ca2+ was detected. These findings enable the direct assessment of CD59 signaling rather than by activation with Ab cross-linking.
GPI-anchored proteins are distributed on membrane domains designated "rafts". Caveolin, a main protein on one type of rafts (caveolae), functions as a key molecule in various types of signaling. To know whether caveolin is involved in CD59 signaling, we tested caveolin expression in blood and blood cell lines in which CD59 signaling is identified. To our surprise none of them expressed caveolin. Only sub line of adult T cell leukemia (ATL) cell lines in a ctivated states expressed caveolin. We are now on the way to elucidate the function of caveolin in CD59 signaling using these positive cells.

  • Research Products

    (13 results)

All Other

All Publications (13 results)

  • [Publications] 畑中道代 ら: "Caveolae構造とcaveolin(1)caveolinとシグナル伝達"神戸常盤短期大学紀要. 22. 31-39 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 池本敏行 ら: "My-4+/LeuM3- molecules and CD19 antigen are down-modulated by low affinity Fc gamma receptor II (CD32) stimulation on CD56-positive B lymphoma cells."Leukemia Lymphoma. 39. 157-164 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] N.A.Begum ら: "Molecular remodelling of human CD46 for xenotransplantation : designing a potent complement regulator without measles virus receptor activity."Immunology. 100. 131-139 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 勝二達也: "Urine levels of CD46 (membrane cofactor protein) are Increased In patients with glomerular diseaases."Clin.Iummunology. 95. 163-169 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 畑中道代 ら: "Expression of caveolin-1 in human leukemia cell lines."Biochem.Biophys.Res.Com.. 253. 382-387 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 畑中道代 ら: "Cellular distribution of a GPI-anchored complement regulatory protein CD59 : homodimerization on the surface on the HeLa and CD59-transfected CHO cel"J.Biochem.. 123. 579-586 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 畑中道代 ら: "別冊領域別症候群sシリーズNo.32免疫症候群-その他の免疫疾患を含めて-(下巻)"日本臨床社. (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hatanaka, M.: "Caveolae structure and caveolin : Implication of caveolin in signal transduction."Bulletin of Kobe Tokiwa College. 22. 31-39 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ikemoto, T., T.Nakagawa, M.Hatanaka, M.Hasegawa, T.Kageyama, M.Hirano, and A.Shimizu.: "My-4+/LeuM3- molecules and CD19 antigen down-modulated by low affinity Fc gamma receptor II (CD32) stimulation on CD56-positive B lymphoma cells."Leukemia Lymphoma. 39. 157-164 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Begum, N.A., Y.Murakami, S.Mikata, M.Matsumoto, M.Hatanaka, S.Nagasawa, T.Kinoshita, and T.Seya.: "Molecular remodeling of human CD46 for xenotransplantation : designing a potent complement regulator without measeles virus receptor activity."Immunology. 100. 131-139 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shoji, T., I.Nakanishi, K.Kunitou, Y.Tsubakihara, Y.Hirooka, Y., Kishi, M.Hatanaka, M.Matsumoto, K.Toyoshima, and T.Seya.: "Urine levels of CD46 (mmbrane cofactor protein, MCP) are increased in patients with glomerular diseases."Clin.Immunol.. 95. 163-169 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hatanaka, M., T.Maeda, T.Ikemoto, H.Mori, T.Seya, and A.Shimizu.: "Expression of caveolin-1 in human T cell leukemia cell lines."Biophis.Biochem.Res.Comm.. 253. 382-387 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hatanaka, M., T.Seya, S.Miyagawa, M.Matsumoto, T.Hara, K.Tanaka, and A.Shimizu.: "Cellular distribution of a GPI-anchored complement regulatory protein, CD59 : Homodimerization on the surface of HeLa and CD59-transfected CHO cells."J.Biochem.. 123. 579-586 (1998)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2002-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi